Your browser doesn't support javascript.
loading
MERLIN: Phase 3a, Multicenter, Randomized, Double-Masked Trial of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.
Khanani, Arshad M; Brown, David M; Jaffe, Glenn J; Wykoff, Charles C; Adiguzel, Eser; Wong, Randall; Meng, Xiangyi; Heier, Jeffrey S.
Afiliação
  • Khanani AM; Sierra Eye Associates, and the University of Nevada, Reno, School of Medicine, Reno, Nevada.
  • Brown DM; Retina Consultants Texas, Retina Consultants of America, Houston, Texas. Electronic address: dmbmd@retinaconsultantstexas.com.
  • Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina.
  • Wykoff CC; Retina Consultants Texas, Retina Consultants of America, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
  • Adiguzel E; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Wong R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Meng X; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts.
Ophthalmology ; 129(9): 974-985, 2022 09.
Article em En | MEDLINE | ID: mdl-35537533
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite Retiniana / Degeneração Macular Exsudativa / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vasculite Retiniana / Degeneração Macular Exsudativa / Degeneração Macular Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article